Glaukos GKOS Business Segments — Net Income Loss

Similar metrics at other companies

TEC

TECHOperating Segments — Operating Income

$56.11M+19.1%

KRYSReportable Segment — Operating Income (Loss)

$53.69M+48.1%

ALGNOperating Segments — Operating Income

$153.57M+36.7%

BOKFOperating Segments — Net Income Loss

$113.8M+21.9%

IONSIonis Operations — Net Income Loss

-$92.53M+37.0%

IONSOperating Segments — Operating Income

-$3.33M+95.2%

Questions, answered.

What is Glaukos's business segments — net income loss?

Glaukos (GKOS) reported business segments — net income loss of -$19.78M in Q1 2026.

How has Glaukos's business segments — net income loss changed year-over-year?

Glaukos's business segments — net income loss decreased by 9.0% year-over-year, from -$18.15M to -$19.78M.

What is the long-term trend for Glaukos's business segments — net income loss?

Over 3 years (2022 to 2025), Glaukos's business segments — net income loss has grown at a 23.7% compound annual growth rate (CAGR), from -$99.2M to -$187.69M.

What does business segments — net income loss mean?

The total profit or loss generated by the ophthalmic therapies business segment after all related expenses.

How do you interpret business segments — net income loss?

Higher net income indicates improved operational efficiency and market success, while a net loss suggests heavy investment in R&D or market penetration costs.

How does business segments — net income loss compare across companies?

Commonly reported as 'Segment Operating Income' by peers in the medical technology sector.